AQEMIA
Pre-clinicalAQEMIA is reinventing drug discovery with physics-based AI, enabling faster invention of new medicines for unmet needs (including oncology).
Founded
2019
Focus
AI / Machine Learning
About
AQEMIA is reinventing drug discovery with physics-based AI, enabling faster invention of new medicines for unmet needs (including oncology).
Funding History
2Total raised: $33.5M
Series A$30MEQT Life SciencesJan 15, 2023
Seed$3.5MElaiaOct 15, 2020
Company Info
TypePrivate
Founded2019
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile